Study Stopped
Study withdrawn at PI\'s request. no patients enrolled.
Fascia Iliaca Compartment Blocks for Pain Control in Hip Fractures
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
This study is comparing the use of a peripheral nerve block and standard opioid pain medications in pain control in hip fractures prior to surgery. A peripheral nerve block is a procedure that injects numbing medicine around a nerve to help decrease the pain, motion, and sensation around the painful site temporarily. The purpose of this study is to evaluate if peripheral nerve blocks are more effective for pain control than just standard opioid pain medication while decreasing the amount of side effects from opioid medication.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Feb 2020
Shorter than P25 for early_phase_1
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 10, 2019
CompletedFirst Posted
Study publicly available on registry
September 12, 2019
CompletedStudy Start
First participant enrolled
February 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedSeptember 4, 2024
August 1, 2024
9 months
September 10, 2019
August 30, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Mean Baseline Pain score on Visual analogue scale at initial encounter
pain is measured 1-10, 1 being the lowest and 10 being the highest
0-60 minutes
Mean Change from baseline pain score on the visual analogue scale
pain is measured 1-10, 1 being the lowest and 10 being the highest
3-8 hours after initial encounter
Study Arms (2)
Non nerve block
NO INTERVENTIONReceives no nerve block
Nerve block
EXPERIMENTALReceives nerve block
Interventions
This group will receive a nerve block consisting of 20mL of 5mg/mL ropivicanine and 0.1mL of 10mg'mL dexamethasone.
Eligibility Criteria
You may qualify if:
- Aged 50 or older, low energy hip fracture, acute hip fracture
You may not qualify if:
- On anticoagulants, hardware present near injection site, preexisting nerve injury.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Guay J, Kopp S. Peripheral nerve blocks for hip fractures in adults. Cochrane Database Syst Rev. 2020 Nov 25;11(11):CD001159. doi: 10.1002/14651858.CD001159.pub3.
PMID: 33238043DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 10, 2019
First Posted
September 12, 2019
Study Start
February 1, 2020
Primary Completion
November 1, 2020
Study Completion
December 1, 2020
Last Updated
September 4, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share